We are live on
!
Find out more
Verrica Pharmaceuticals
VRCA
VRCA
49 hedge funds and large institutions have $115M invested in Verrica Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 17 increasing their positions, 12 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
42% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 12
2% more capital invested
Capital invested by funds: $112M → $115M (+$2.39M)
0.29% less ownership
Funds ownership: 3.63% → 3.33% (-0.29%)
8% less funds holding
Funds holding: 53 → 49 (-4)
34% less call options, than puts
Call options by funds: $329K | Put options by funds: $502K
44% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 9
Holders
49
Holders Change
-4
Holders Change %
-7.55%
% of All Funds
0.86%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
17
Reduced
12
Closed
9
Calls
$329K
Puts
$502K
Net Calls
-$173K
Net Calls Change
-$174K
Top Buyers
Top Sellers
| 1 |
Millennium Management
New York
|
-$3.4M |
| 2 |
ACM
Altium Capital Management
New York
|
-$3.02M |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$1.05M |
| 4 |
Morgan Stanley
New York
|
-$869K |
| 5 |
BlackRock
New York
|
-$646K |
